Sjogren's Syndrome (cont.)

Medical Author:
Medical Editor:

Conclusion

Sjögren's syndrome is an area of active immunology research. Many new treatments will be available in the near future. Recent research has suggested that rituximab (Rituxan) may be beneficial for many features of Sjögren's syndrome.

Sjögren's syndrome is named after a Swedish ophthalmologist, Henrik Sjögren. In the early 1900s, Sjögren called the syndrome "keratoconjunctivitis sicca." The name sicca syndrome is technically now used only to describe the combination of dryness of the mouth and eyes, regardless of cause. The term sicca refers to the dryness of the eyes (and mouth).

REFERENCES:

Klippel, J.H., et al. Primer on the Rheumatic Diseases. New York: Springer, 2008.

Koopman, William, et al., eds. Clinical Primer of Rheumatology. Philadelphia: Lippincott Williams & Wilkins, 2003.

Ruddy, Shaun, et al., eds. Kelley's Textbook of Rheumatology. 6th ed. Philadelphia: W.B. Saunders Co., 2001.

Additional resources from WebMD Boots UK on Sjögrens Syndrome


Medically Reviewed by a Doctor on 9/26/2013

Patient Comments

Viewers share their comments

Sjogren's Syndrome - Describe Your Experience Question: Please describe your experience with sjogren's syndrome.
Sjogren's Syndrome - Symptoms Question: What symptoms and signs did you experience with Sjogren's syndrome?
Sjogren's Syndrome - Prognosis Question: What is the prognosis for your Sjogren's syndrome?
Sjogren's Syndrome - Treatment and Diet Question: What treatment has been effective for your Sjogren's syndrome? Have you made any dietary changes, and have they been effective in managing your Sjogren's syndrome?